Products and Services

Device company RxPack has joined the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) as an associate member, the company said. RxPack is a joint venture between Lindal Group and Coster Group that was formed… Read more . . .

Gerresheimer has announced that it will manufacture supplies of Iconovo’s IcoOne dry powder inhaler for Phase 3 trials of ISR’s intranasal COVID-19 vaccine and has started the design process for molding and manufacturing the device.… Read more . . .

CDMO Upperton Pharma Solutions, which recently launched a new nasal delivery development platform, has announced that it will invest £15 million in a new 50,000 sq ft facility in Nottingham, UK that will include new… Read more . . .

CDMO Lonza has announced that it is adding dry powder inhaler testing capabilities at its facility in Tampa, FL, USA for increased DPI development capacity. Lonza, which established a Center of Excellence for DPI particle… Read more . . .

Aston University spin out Aston Particle Technologies (APT) has closed a £1 million funding round according to lead investor DSW Ventures. The funding will be used for scale up of APT’s isothermal dry particle coating… Read more . . .

Scottish nebulizer developer Nebu-Flow has raised £1.7 million “to continue the commercialization and delivery of next generation respiratory pharmaceuticals,” the company has announced on social media. The funding round was led by Foresight Williams Technology.… Read more . . .

Zeteo Biomedical has announced the launch of its ZEOx1 OrionMRQ metered dose nasal device for delivery of drugs and vaccines. Zeteo’s ZEOx1 devices are designed for intranasal delivery of liquid formulations, and its ZEOx2 devices… Read more . . .

DPI developer Iconovo has announced that Galenica AB will offer cGMP manufacturing of Iconovo’s ICOone single dose disposable DPI for clinical trials, so that customers wanting to develop an inhaled drug delivered by the ICOone… Read more . . .